MARAMPON, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 58
AS - Asia 57
EU - Europa 55
SA - Sud America 6
Totale 176
Nazione #
US - Stati Uniti d'America 56
IT - Italia 40
SG - Singapore 19
BD - Bangladesh 15
CN - Cina 9
HK - Hong Kong 7
BR - Brasile 4
FI - Finlandia 4
DE - Germania 3
AR - Argentina 2
ID - Indonesia 2
IN - India 2
CA - Canada 1
FR - Francia 1
GB - Regno Unito 1
GR - Grecia 1
HU - Ungheria 1
IE - Irlanda 1
JM - Giamaica 1
PL - Polonia 1
RU - Federazione Russa 1
TJ - Tagikistan 1
TR - Turchia 1
UA - Ucraina 1
VN - Vietnam 1
Totale 176
Città #
Ashburn 13
Brescia 11
San Jose 10
Singapore 10
Council Bluffs 7
Hong Kong 7
New York 5
Chandler 4
Milan 3
Verona 3
Beijing 2
Dallas 2
Lappeenranta 2
Los Angeles 2
Lumezzane 2
Marcheno 2
Munich 2
Arcene 1
Athens 1
Bologna 1
Brentwood 1
Budapest 1
Buffalo 1
Cachoeiro de Itapemirim 1
Camaragibe 1
Carpinone 1
Charleston 1
Chennai 1
City of London 1
Dhaka 1
Dublin 1
Dushanbe 1
Florence 1
Fortaleza 1
Foshan 1
Frankfurt am Main 1
Haiphong 1
Helsinki 1
Istanbul 1
Jakarta 1
Kingston 1
Lanús 1
Lauterbourg 1
Mohyliv-Podilskyi 1
Naples 1
Patna 1
Pavia 1
Pierrefonds 1
Rancho Palos Verdes 1
Redondo Beach 1
Santa Clara 1
Santo Antônio 1
Serang 1
Shanghai 1
The Dalles 1
Turku 1
Villa Carlos Paz 1
Warsaw 1
Totale 128
Nome #
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 133
Microbiota Modulation of Radiosensitiveness and Toxicity in Gastrointestinal Cancers: What Radiation Oncologists Need to Know—A Review on Behalf of the Italian Association of Radiobiology (AIRB) 40
Didox, a ribonucleotide reductase inhibitor with iron chelator properties, counteracts the in vitro and in vivo growth of rhabdomyosarcoma cells 6
Totale 179
Categoria #
all - tutte 1.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.266


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202312 0 0 0 1 6 2 3 0 0 0 0 0
2023/202420 0 0 3 2 0 2 2 6 3 0 1 1
2024/202532 1 0 1 5 2 2 3 1 4 2 5 6
2025/2026115 7 9 7 3 8 2 9 8 17 13 20 12
Totale 179